It can be mentioned that genetic variability in AMP metabolism might be clinically applicable resulting from highly polymorphic mother nature of CYP2D6. In concept, CYP2D6 inadequate metabolizers may be anticipated to demand smaller doses of AMP and/or be more prone to adverse effects from routine medical doses, although CYP2D6 ultra-rapid metaboli